Tislelizumab plus chemotherapy received FDA approval as a frontline therapy for individuals with unresectable or metastatic esophageal squamous cell carcinoma (ESCC) whose tumors express PD-L1.
This investigation analyzes public data on adult patients from the 2017 National Health Interview Survey, including how often they were treated with respect and could see health care providers who shared their cultural views.
The Center on Health Equity & Access delves into the latest research, policy shifts, and expert viewpoints on advancing equity and improving access to care.
A new clinical trial finds no cardiovascular benefit from high-dose multivitamins, with or without chelation therapy, in patients with diabetes and past myocardial infarction.
This new report is not the first to highlight cervical cancer disparities among women in the US.
Brianna Rhue, OD, FAAO, discusses the pitfalls of myopia treatment and accessibility of that treatment.
These findings may not be generalizable to uninsured patients with ovarian cancer, who face unique barriers to care compared with insured patients.
Rising rates of metabolic dysfunction–associated steatohepatitis indicate a need for public health interventions.
Karen Winkfield, MD, PhD, addresses the importance of inclusive clinical trial participation and meeting patients where they are.
Effective communication, cultural competence, and patient advocacy are keys to overcoming language barriers in eye care, as highlighted in a presentation at the Southeastern Congress of Optometry 2025.
Brianna Rhue, OD, FAAO, discussed novel approaches to myopia management and how they can be implemented into clinical practice.
Advancements in dry eye care focus on improvements seen in patients treated with cyclosporine 0.09% following inadequate responses at a lower dose, and customizable scleral lenses offer a nonsurgical option for Salzmann nodular degeneration, enhancing vision and comfort.
New anti–vascular endothelial growth factor (VEGF) therapies are improving retinal disease management by providing patients with more treatment options, optimizing timing, and introducing innovative administration methods.
Multimodal imaging is a useful tool in diagnosing and managing age-related macular degeneration (AMD), according to Julie Rodman, OD, MS, FAAO.
Nate Lighthizer, OD, FAAO, discusses laser therapy and how attendees at Southeastern Educational Congress of Optometry (SECO) 2025 got hands-on experience at the conference.
The effectiveness of laser peripheral iridotomy (LPI) in managing angle closure glaucoma is uncertain, with studies suggesting that phacoemulsification may provide better intraocular pressure control and long-term outcomes, as discussed at the Southeastern Congress of Optometry 2025.
The 2025 guideline introduces notable updates including refined recommendations for dual antiplatelet therapy, cardiogenic shock management, and secondary prevention.
Several rare disease patient populations received their first-ever FDA-approved drug since Rare Disease Day last year, signifying progress in closing treatment gaps for rare disease.
Mile Brujic, OD, FAAO, discusses his new research being presented at the Southeastern Educational Congress of Optometry 2025 meeting concerning dry eye treatment.
The cause of age-related macular degeneration can be varied and symptoms are often not recognized immediately, according to Hasenin Al-khersan, MD.
Julie Rodman, OD, MS, FAAO, discusses how optical coherence tomography angiography (OCT-A) can be used to diagnose and manage diabetic retinopathy.
Artificial intelligence, surgical innovations, and wearable technology are transforming eye care, enhancing patient outcomes and clinical efficiency, as discussed during the keynote presentation at the Southeastern Congress of Optometry (SECO) 2025.
Activities of daily life, education, and employment were areas of difficulty in the transition to adulthood for patients with Duchenne muscular dystrophy (DMD) or Becker muscular dystrophy (BMD), but those who had more siblings reported being more ready to transition to adult life.
The classification of spinal muscular atrophy (SMA) subtypes, the influence of SMN2 gene copies on disease severity, treatment effects on disease progression, age-related differences, long-term management strategies, and adequate muscle function monitoring are all important aspects of SMA care.
Food recalls numbered 300 in 2024, indicating that increased vigilance may be required from both consumers and the FDA.
I. Benjamin Gaddie, OD, FAAO, summarized the best forms of treating and managing demodex blepharitis.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Selective laser trabeculoplasty, artificial intelligence–driven diagnostics, and new drug delivery systems are transforming glaucoma care and improving patient outcomes, according to a panel of experts.
Adverse physical functions were indicative of reduced survival and increased risk of immune effector cell–associated neurotoxicity syndrome (ICANS) in patients with non-Hodgkin lymphoma (NHL) previously treated with chimeric antigen receptor T-cell therapy.
Time costs, often overlooked in health care, create economic burdens for patients and caregivers, impacting income and well-being.
